Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) FCF Margin (2019 - 2025)

Historic FCF Margin for AVITA Medical (RCEL) over the last 7 years, with Q4 2025 value amounting to 2.99%.

  • AVITA Medical's FCF Margin fell 946700.0% to 2.99% in Q4 2025 from the same period last year, while for Dec 2025 it was 20.68%, marking a year-over-year increase of 512600.0%. This contributed to the annual value of 32.82% for FY2025, which is 7121800.0% up from last year.
  • According to the latest figures from Q4 2025, AVITA Medical's FCF Margin is 2.99%, which was down 946700.0% from 36.06% recorded in Q3 2025.
  • AVITA Medical's FCF Margin's 5-year high stood at 91.68% during Q4 2024, with a 5-year trough of 198.23% in Q1 2024.
  • For the 5-year period, AVITA Medical's FCF Margin averaged around 62.66%, with its median value being 63.91% (2023).
  • Over the last 5 years, AVITA Medical's FCF Margin had its largest YoY gain of 1702900bps in 2024, and its largest YoY loss of -1095300bps in 2024.
  • Quarter analysis of 5 years shows AVITA Medical's FCF Margin stood at 9.1% in 2021, then plummeted by -307bps to 37.08% in 2022, then crashed by -112bps to 78.61% in 2023, then surged by 217bps to 91.68% in 2024, then plummeted by -103bps to 2.99% in 2025.
  • Its last three reported values are 2.99% in Q4 2025, 36.06% for Q3 2025, and 58.38% during Q2 2025.